Clinical trials
Bioavailability clinical trials
Below are recruiting bioavailability clinical trials, each written for real people, not researchers. We’re tracking 38 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06142084Recruiting
Digesting plant proteins: a study in people with ileostomy
This study looks at how well your body digests different plant-based proteins. You may help by providing samples through your ileostomy, so researchers can understand which proteins are easiest to absorb.
ÖrebroAges 18–75 - NCT07063173Recruiting
Tart cherry drink and bar absorption study
This trial looks at how well your body absorbs nutrients from tart cherry extract in a drink and a bar. It might help if you're interested in how food ingredients work in the body.
Natick, MassachusettsAges 17–39 - NCT07868861RecruitingPhase 1
Nasal ondansetron versus IV injection in healthy adults
This trial tests a new nasal spray form of ondansetron (a medicine that prevents nausea and vomiting) to see how well the body absorbs it compared with the IV (into the vein) form. It is for healthy adults to help understand how the nasal spray works.
JerusalemAges 18–65 - NCT07780383RecruitingPhase 1
Single-dose study for healthy adults and early Alzheimer's participants
This trial tests a new investigational drug, BMS-986446, given as a single dose to healthy volunteers and multiple doses to people with early Alzheimer's disease. It aims to understand how the drug moves in the body, its safety, and whether it triggers an immune response, which could help guide future treatment for Alzheimer's.
Anaheim, CaliforniaAges 18–80 - NCT07723833RecruitingPhase 1
Study of different forms of elecoglipron in healthy volunteers
This trial tests how different versions of the drug elecoglipron are absorbed by the body and if they are safe. It is for healthy people to help find the best way to take the medicine.
Glendale, CaliforniaAges 18–55 - NCT07712640RecruitingPhase 1
Comparing two tablet forms of BGB-58067 and food effect
This study tests how two different tablet versions of the study drug BGB-58067 enter the body and how food affects the drug. Healthy volunteers take the drug to help understand the best way to give it in future trials.
Adelaide, South AustraliaAges 18–65 - NCT07673601RecruitingPhase 1
Study of adimanebart in healthy adults
This study tests how a single injection of adimanebart is absorbed by the body and how it travels through the bloodstream. It is for healthy adults to help understand the drug's behavior.
MontrealAges 18–65 - NCT07665944Recruiting
Hydroponic vs conventional spinach smoothie study
This study compares how spinach smoothies made from hydroponically-grown spinach versus conventionally-grown spinach affect your blood pressure and the levels of healthy nitrates in your saliva. The information gathered can help people make better food choices for heart health.
Plymouth, DevonAges 18–60 - NCT07629999RecruitingPhase 1
Safety study of experimental drug BMS-986533 in healthy people
This early-stage study tests how a new experimental drug (BMS-986533) is processed and tolerated by healthy volunteers. Researchers will also check how food and stomach acid affect the drug, and whether it interacts with other medications.
Lincoln, NebraskaAges 18–55 - NCT07634770RecruitingPhase 1
Oral insulin study compared to injected insulin
This early-stage study tests whether a new oral (swallowed) form of insulin called SCD0503 works as well as regular injected insulin in men with type 1 diabetes. Researchers will also check how food affects how your body absorbs the oral insulin.
Neuss, North Rhine-WestphaliaAges 18–64 - NCT07636928RecruitingPhase 1
Study of how the body absorbs a new HIV medicine
This early-stage study tests a new HIV medication (VH4524184) to understand how your body absorbs and processes it. You'll take a single dose of the medication with a small amount of radioactive tracer, which helps researchers track where the drug goes in your body.
GroningenAges 18–55 - NCT07628881RecruitingPhase 1
How Your Body Processes a New Tablet Medicine With and Without Food
This early-stage study tests how a new medicine called sonrotoclax is absorbed and processed by your body when taken as a tablet with and without food. Researchers want to understand the best way to take this medicine to help it work effectively.
Joondalup, Western AustraliaAges 18–60 - NCT07610005RecruitingPhase 1
Varegacestat dosing study in healthy adults
This early-stage study tests how the body absorbs and processes a new drug called varegacestat in healthy people. Researchers will compare different ways of giving the drug to understand how well it works.
Tempe, ArizonaAges 18–55 - NCT07612020RecruitingPhase 1
How Well a New Injection Works Compared to IV
This study tests a new medicine called empasiprubart that can be injected under the skin using an autoinjector (like an EpiPen). Researchers want to see how much of the medicine gets into your bloodstream and whether the injection works as well as an IV infusion. You'll be a healthy volunteer helping them understand if this new delivery method is effective.
Mount Royal, QuebecAges 18–65 - NCT07564674Recruiting
How Your Body Processes Broccoli Extract Supplements
This study tests how well your body absorbs and uses broccoli extract supplements. Researchers want to understand if these supplements deliver their plant-based benefits effectively, which could help improve future supplement design.
Corvallis, OregonAges 18–60 - NCT07549919RecruitingPhase 1
Food Effects on a New Experimental Drug in Healthy Men
This study tests how food affects how the body absorbs and processes a new experimental drug called AJ201. Researchers will give the drug to healthy men with and without food to see if it makes a difference, and they'll check for any side effects.
Los Alamitos, CaliforniaAges 18–55 - NCT07539415RecruitingPhase 1
Safety and effectiveness study of new injection in healthy adults
This study tests a new experimental injection in healthy volunteers to see if it's safe and how well the body absorbs it. Researchers will compare it with other similar treatments to understand how it works.
SeoulAges 19–64 - NCT07521189Recruiting
How Diet Type Affects Protein Digestion in Young and Older Adults
This study compares how well the body digests protein from plant-based versus meat-based diets in young adults (18–23) and older adults (65–75). Researchers want to understand if age and diet type affect how efficiently your body uses protein from food.
BobignyAges 18–75 - NCT07503873RecruitingPhase 2
Study of ublituximab injection for multiple sclerosis
This trial tests a new way to give the drug ublituximab (an injection under the skin) to people with relapsing multiple sclerosis. It compares different injection sites and a special auto-injector device to see how the body absorbs the drug and if it's safe.
BihaćAges 18–65 - NCT07489482RecruitingPhase 1
Comparing SHR-3167 injection bioavailability and safety
This trial tests how a new medicine (SHR-3167) is absorbed by the body and checks for side effects. Healthy volunteers ages 18-55 can join to help researchers understand how this drug works.
Changsha, HunanAges 18–55 - NCT07453784RecruitingPhase 1
Testing a tiny tablet of obefazimod in healthy adults
This study tests how a new form of the medicine obefazimod (a tiny tablet) is absorbed by the body, and whether people find it easy to take. It is for healthy adults ages 18–55 who are not taking other medications and are generally well.
NottinghamAges 18–55 - NCT07448155RecruitingPhase 1
Testing a new drug in healthy volunteers
This study tests a new medicine (INCA033989) given as a shot or IV in healthy adults to see how the body processes it and if it's safe.
Tempe, ArizonaAges 18–55 - NCT07401381RecruitingPhase 1
Injectable vs. oral letrozole in early breast cancer
This study compares a new injectable form of the drug letrozole with the standard oral pill. It aims to find out if the injection works as well as the pill for women who have already taken letrozole for their early breast cancer and have finished their initial treatment.
Beverly Hills, CaliforniaAges 18–80 - NCT07334080RecruitingPhase 1
Study of how food affects ECC4703 in healthy adults
This trial tests how taking the study drug ECC4703 with or without food affects its levels in the body, and how well the body absorbs it. It helps find the best way to take the drug.
Adelaide, South AustraliaAges 18–65
Hear when a new Bioavailability trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for bioavailability?
- Yes. Clin2 currently lists 38 recruiting bioavailability studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a bioavailability trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a bioavailability trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.